Search Results - "Pissurlenkar, Raghuvir R. S."

Refine Results
  1. 1

    Interaction of multimicrobial synthetic inhibitor 1,2-bis(2-benzimidazolyl)-1,2-ethanediol with serum albumin: spectroscopic and computational studies by Kamtekar, Nayana, Pandey, Anita, Agrawal, Neeraj, Pissurlenkar, Raghuvir R S, Borana, Mohanish, Ahmad, Basir

    Published in PloS one (04-01-2013)
    “…The molecule, 1,2-Bis(2-benzimidazolyl)-1,2-ethanediol (BBE) is known to act as a selective inhibitor of poliovirus, rhinovirus, Candida albicans, several…”
    Get full text
    Journal Article
  2. 2

    Size-Induced Chiral Discrimination Switching by (S)-(−)-2(α-Hydroxyethyl)Benzimidazole-Derived Azacrowns by Pandey, Anita D., Mohammed, Hasan, Pissurlenkar, Raghuvir R. S., Karnik, Anil V.

    Published in ChemPlusChem (Weinheim, Germany) (01-03-2015)
    “…(S)‐(−)‐2‐(α‐Hydroxyethyl)benzimidazole (1)‐derived diastereomeric monoaza‐[18]crown‐6 compounds 5 and 6 were synthesised with an additional chiral centre…”
    Get full text
    Journal Article
  3. 3

    Synthesis, in vitro antitubercular activity and 3D-QSAR study of 1,4-dihydropyridines by Manvar, Atul T, Pissurlenkar, Raghuvir R. S, Virsodia, Vijay R, Upadhyay, Kuldip D, Manvar, Dinesh R, Mishra, Arun K, Acharya, Hrishikesh D, Parecha, Alpesh R, Dholakia, Chintan D, Shah, Anamik K, Coutinho, Evans C

    Published in Molecular diversity (01-05-2010)
    “…In continuation of our research program on new antitubercular agents, this article is a report of the synthesis of 97 various symmetrical, unsymmetrical, and…”
    Get full text
    Journal Article
  4. 4

    Effects of 2-amino-8-hydroxyquinoline interaction on the conformation of physiological isomers of human serum albumin by Shiriskar, Sonali M., Agarwal, Neeraj, Pissurlenkar, Raghuvir R. S., Ahmad, Basir

    Published in European biophysics journal (01-05-2015)
    “…The methods of synthetic chemistry create small molecules rapidly for screening, and ligand–protein interaction studies provide information on how a potential…”
    Get full text
    Journal Article
  5. 5

    Valsartan inclusion by methyl-β-cyclodextrin: Thermodynamics, molecular modelling, Tween 80 effect and evaluation by Chadha, Renu, Bala, Madhu, Arora, Poonam, Jain, D.V.S., Pissurlenkar, Raghuvir R.S., Coutinho, Evans C.

    Published in Carbohydrate polymers (15-03-2014)
    “…•The effect of M-β-CD and Tween 80 (0.5%, v/v) on solubility and biological performance of valsartan has been evaluated.•The mode of interaction, stoichiometry…”
    Get full text
    Journal Article
  6. 6

    Molecular modeling studies, synthesis, and biological evaluation of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR) inhibitors by Morde, Varun A, Shaikh, Mushtaque S, Pissurlenkar, Raghuvir R. S, Coutinho, Evans C

    Published in Molecular diversity (01-11-2009)
    “…The search for new antimalarial agents is necessary as current drugs in the market become vulnerable due to the emergence of resistance strains of Plasmodium…”
    Get full text
    Journal Article
  7. 7

    Synthesis, screening for antitubercular activity and 3D-QSAR studies of substituted N-phenyl-6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydro-pyrimidine-5-carboxamides by Virsodia, Vijay, Pissurlenkar, Raghuvir R.S., Manvar, Dinesh, Dholakia, Chintan, Adlakha, Priti, Shah, Anamik, Coutinho, Evans C.

    Published in European journal of medicinal chemistry (01-10-2008)
    “…Multi-drug resistance to commonly used antitubercular drugs has propelled the development of new structural classes of antitubercular agents. This paper…”
    Get full text
    Journal Article
  8. 8

    Telmisartan complex augments solubility, dissolution and drug delivery in prostate cancer cells by Kaur, Manveet, Bhatia, Richa Kaur, Pissurlenkar, Raghuvir R.S., Coutinho, Evans C., Jain, Upendra Kumar, Katare, Om Prakash, Chandra, Ramesh, Madan, Jitender

    Published in Carbohydrate polymers (30-01-2014)
    “…•Telmisartan inhibits the growth of prostate cancer cells with low therapeutic index.•We have synthesized a complex of telmisartan using the carbohydrate…”
    Get full text
    Journal Article
  9. 9

    Furo-Fused BINOL Based Crown as a Fluorescent Chiral Sensor for Enantioselective Recognition of Phenylethylamine and Ethyl Ester of Valine by Upadhyay, Sunil P, Pissurlenkar, Raghuvir R. S, Coutinho, Evans C, Karnik, Anil V

    Published in Journal of organic chemistry (20-07-2007)
    “…A furo-fused BINOL based chiral crown was developed as an enantioselective chiral sensor for phenylethylamine and ethyl ester of valine. Fusion of furan to…”
    Get full text
    Journal Article
  10. 10

    HomoSAR: Bridging comparative protein modeling with quantitative structural activity relationship to design new peptides by Borkar, Mahesh R., Pissurlenkar, Raghuvir R. S., Coutinho, Evans C.

    Published in Journal of computational chemistry (15-11-2013)
    “…Peptides play significant roles in the biological world. To optimize activity for a specific therapeutic target, peptide library synthesis is inevitable; which…”
    Get full text
    Journal Article
  11. 11

    Comprehensive computational study in the identification of novel potential cholesterol lowering agents targeting proprotein convertase subtilisin/kexin type 9 by Maliwal, Deepika, Pissurlenkar, Raghuvir R. S., Telvekar, Vikas

    “…The enzymatic target proprotein convertase subtilisin/kexin type 9 (PCSK9) is critically involved in the regulation of the lipoprotein metabolism leading to…”
    Get full text
    Journal Article
  12. 12

    Targeting Dormant Tuberculosis Bacilli: Results for Molecules with a Novel Pyrimidone Scaffold by Joshi, Rohit R., Barchha, Avinash, Khedkar, Vijay M., Pissurlenkar, Raghuvir R. S., Sarkar, Sampa, Sarkar, Dhiman, Joshi, Rohini R., Joshi, Ramesh A., Shah, Anamik K., Coutinho, Evans C.

    Published in Chemical biology & drug design (01-02-2015)
    “…Our inability to completely control TB has been due in part to the presence of dormant mycobacteria. This also renders drug regimens ineffective and is the…”
    Get full text
    Journal Article
  13. 13

    Characterization of pioglitazone cyclodextrin complexes: Molecular modeling to in vivo evaluation by Bramhane, Dinesh, Kulkarni, Preethi, Martis, Elvis, Pissurlenkar, Raghuvir, Coutinho, Evans, Nagarsenker, Mangal

    Published in Journal of pharmacy & bioallied science (01-04-2016)
    “…Aims: The objective of present study was to study the influence of different β-cyclodextrin derivatives and different methods of complexation on aqueous…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Curcumin and kaempferol prevent lysozyme fibril formation by modulating aggregation kinetic parameters by Borana, Mohanish S., Mishra, Pushpa, Pissurlenkar, Raghuvir R.S., Hosur, Ramakrishna V., Ahmad, Basir

    Published in Biochimica et biophysica acta (01-03-2014)
    “…Interaction of small molecule inhibitors with protein aggregates has been studied extensively, but how these inhibitors modulate aggregation kinetic parameters…”
    Get full text
    Journal Article
  16. 16
  17. 17

    New thiazolyl-isoxazole derivatives as potential anti-infective agents: design, synthesis, in vitro and in silico antimicrobial efficacy by Bhoye, Manish R, Shinde, Abhijit, Shaikh, Abdul Latif N, Shisode, Vilas, Chavan, Abhijit, Maliwal, Deepika, Pissurlenkar, Raghuvir R S, Mhaske, Pravin C

    “…Antimicrobial resistance threatens the efficacious prevention and treatment of infectious diseases caused by microorganisms. To combat microbial infections,…”
    Get full text
    Journal Article
  18. 18

    Physical basis for the ofloxacin-induced acceleration of lysozyme aggregation and polymorphism in amyloid fibrils by Muthu, Shivani A., Mothi, Nivin, Shiriskar, Sonali M., Pissurlenkar, Raghuvir R.S., Kumar, Anil, Ahmad, Basir

    Published in Archives of biochemistry and biophysics (15-02-2016)
    “…Aggregation of globular proteins is an intractable problem which generally originates from partially folded structures. The partially folded structures first…”
    Get full text
    Journal Article
  19. 19
  20. 20